The use of deodorants/antiperspirants does not constitute a risk factor for breast cancer;L'utilisation de déodorants/antitranspirants ne constitue pas un risque de cancer du sein

Bulletin du Cancer

Volumn 95, Issue 9, 2008, Pages 871-880

  Namer, Moïse ^a,b   Luporsi, Elisabeth ^c   Gligorov, Joseph ^d   Lokiec, François ^e   Spielmann, Marc ^f  

^a APREMAS   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

^c CENTRE ALEXIS VAUTRIN   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e CENTRE RENÉ HUGUENIN   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Aluminium; Breast cancer; Deodorants antiperspirants; Parabens; Risk factor

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; ALUMINUM SALT; ANTIPERSPIRANT AGENT; DEODORANT AGENT;

ARTICLE; BREAST CANCER; CANCER RESEARCH; CANCER RISK; CAUSAL ATTRIBUTION; EUROPE; FRANCE; HEALTH CARE ORGANIZATION; HUMAN; INFORMATION RETRIEVAL; MEDICAL EXPERT; MEDICAL LITERATURE; MEDLINE; SYSTEMATIC REVIEW; UNITED STATES;

ALUMINUM COMPOUNDS; ANTIPERSPIRANTS; BREAST NEOPLASMS; DEODORANTS; FEMALE; HUMANS; PARABENS; RISK FACTORS;

EID: 53849104778     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2008.0679     Document Type: Article

References (38)

1. Trétarre B, Guizard AV, Fontaine D, et al. Cancer du sein chez la femme : incidence et mortalité, France 2000. BEH 2004 ; 44 : 209-10.
2. Hill C, Doyon F. La fréquence des cancers en France en 2005 : évolution de la mortalité depuis 1950 et résumé du rapport sur les causes de cancer. Bull Cancer 2008 ; 95(1) : 5-10.
3. Brenner H, Gondos A, Arndt V. Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. J Clin Oncol 2007 ; 25(22) : 3274-80.
4. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006 ; 354(3) : 270-82.
5. Glass AG, Lacey Jr. JV, Carreon JD, Hoover RN. Breast cancer incidence, 1980-2006 : combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 2007 ; 99(15) : 1152-61 ; (Epub 2007 Jul 24).
6. Khan HN, Bendall S, Bates T. is hormone replacement therapy-related breast cancer more favorable? A case-control study. Breast J 2007 ; 13(5) : 496-500.
7. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 2007 ; 356(16) : 1670-4.
8. McGrath KG. An earlier age of breast cancer diagnosis related to more frequent use of antiperspirants/deodorants and underarm shaving. Eur J Cancer Prev 2003 ; 12(6) : 479-85.
9. Darbre PD. Aluminium, antiperspirants and breast cancer. J Inorg Biocbem 2005 ; 99(9) : 1912-9.
10. Afssaps. Evaluation du risque lié à l'utilisation des aluminiums dans les produits cosmétiques. Vigilances février 2006 - Bulletin no31 : 3.
11. Food and Drug Administration (FDA). http://www.fda.gov/fdac/features/ 2005/405_sweat.html#FDA. National Cancer Institute (NCI). Fact Sheet 2.10. How to evaluate health information on the Internet : questions and answers (http ://www.cancer.gov/cancertopics/factsheet/Risk/AP-Deo#q2).
12. Lorette G. Parabens in cosmetics : something to worry about? Presse Med 2006 ; 35(2 Pt 1) : 187-8.
13. In : Laden K, Felger CB, eds. Antiperspirants and Deodorants 2nd Edition. NY and Basel : Marcel Dekker Inc (Cosmetic Science and Technology Series, vol 20), 1999 : 404.
14. Mirick DK, Davis S, Thomas DB. Antiperspirant use and the risk of breast cancer. J Natl Cancer Inst 2002 ; 94(20) : 1578-80.
15. McLaughlin JK, Lipworth L, Fryzek JP, Ye W, Tarone RE, Nyren O. Long-term cancer risk among Swedish women wirh cosmetic breast implants : an update of a nationwide study. J Natl Cancer Inst 2006 ; 98(8) : 557-60.
16. Guillard O, Fauconneau B, Olichon D, Dedieu G, Deloncle R. Hyperaluminemia in a woman using an aluminum-containing antiperspirant for 4 years. Am J Med 2004 ; 117(12) : 956-9.
17. Flarend R, Bin T, Elmore D, Hem SL. A preliminary study of the dermal absorption of aluminium from antiperspirants using aluminium-26. Food Chem Toxicol 2001 ; 39(2) : 163-8.
18. Darbre PD, Aljarrah A, Miller WR, Coldham NG, Sauer MJ, Pope GS. Concentration of parabens in human breast tumours. J Appl Toxicol 2007 ; 24(1) : 5-13.
19. Quatrale RP, Thomas EL, Birnbaum JE. The site of antiperspirant action by aluminum salts in the eccrine sweat glands of the axilla. J Soc Cosmet Chem 1985 ; 36(6) : 435-40.
20. Hart MM, Adamson RH. Antitumor activity and toxicity of salts of inorganic group IIIa metals : aluminum, gallium, indium, and thallium. Proc Natl Acad Sci USA 1971 ; 68(7) : 1623-6.
21. Martin MB, Reiter R, Pham T, Avellanet YR, Camara J, Lahm M, et al. Estrogen-like activity of metals in MCF7 breasr cancer cells. Endocrinology 2003 ; 144(6) : 2425-36.
22. Oneda S, Takasaki T, Kuriwaki K, Ohi Y, Umekita Y, Hatanaka S, et al. Chronic toxicity and tumorigenicity study of aluminum potassium sulfate in B6C3F1 Mice. In Vivo 1994 ; 8(3) : 271-825.
23. Schroeder HA, Mitchener M. Life-term studies in rats : effects of aluminium, barium, beryllium, and tungsten. J Nutr 1975 ; 105(4) : 421-7.
24. Darbre PD. Underarm cosmetics and breast cancer. J Appl Toxicol 2003 ; 23(2) : 89-95.
25. Darbre PD. Metallo-estrogens : an emerging class of inorganic xenoestrogens with potential to add to the oestrogenic burden of the human breast. J Appl Toxicol 2006 ; 26(3) : 191-7.
26. Gikas PD, Mansfield L, Mokbel K. Do underarm cosmetics cause breast cancer? Int J Fertil Womens Med 2007 ; 49(5) : 212-4.
27. Höltze E. Topical pharmacological treatment. Curr Probl Dermatol 2002 ; 30 : 30-43.
28. Höltze E. Antiperspirants. In : Gabard B, ed. Dermatopharmacology of Topical Preparations. Berlin : Springer-Verlag, 2000 : 401-16.
29. Pennington JA, Schoen SA. Estimates of dietary exposure to aluminium. Food Addit Contam 1995 ; 12(1) : 119-28.
30. Harvey PW, Everett DJ. Significance of the detection of esters of p-hydroxybenzoic acid (parabens) in human breast tumours. J Appl Toxicol 2004 ; 24(1) : 1-4.
31. Doll R. Sir Austin Bradford Hill and the progress of medical science. BMJ 1992 ; 305(6868) : 1521-6.
32. Hill BA. The environment and disease : association or causation? Proc R Soc Med 1965 ; 58 : 295-300.
33. Susser M. Judgement and causal inference : criteria in epidemiologic studies. Am J Epidemiol 1977 ; 105(1) : 1-15.
34. Roush GC, Holford TR, Schymura MJ, et al. Female breast. In : Roush GC, Holford TR, Schymura MJ, White C, eds. Cancer risk and incidence trends : the Connecticut Perspective. Cambridge : Hemisphere, 1987 : 223-38.
35. US Cosmetic and Toiletries Market (2001). Market studies 2001-02 Edition. North Carolina: 42-43, 72.
36. Chyz A, Faith J, Friedenreich C, Goldberg M, Lenz S. Introduction. In : Initiative canadienne sur le cancer du sein. Rapport du groupe de travail sur la prévention primaire du cancer du sein. Canada. 2001 : 1-7.
37. SEER Incidence public-Use Database, 1973-1998. [CD ROM]. (2001). US Department of Health and Human Services. National Cancer Institute.
38. Hill C, Doyon F. Cancer prevalence in France. Bull Cancer 2001 ; 88(10) : 1019-22.